Gaceta Médica de México (Apr 2021)

Factores de riesgo asociados a neuropatía diabética en pacientes mexicanos

  • Katy Sánchez-Pozos,
  • Jazmín Monroy-Escutia,
  • Joel Jaimes-Santoyo,
  • Mª de los Ángeles Granados-Silvestre,
  • Marta Menjivar,
  • Mª Guadalupe Ortiz-López

DOI
https://doi.org/10.24875/CIRU.20000243
Journal volume & issue
Vol. 89, no. 2

Abstract

Read online

Introduction: Diabetic neuropathy (DN) is one of the most common complications of type 2 diabetes (T2D) and is a leading cause of lower limb amputation. The aim of the present study was to evaluate the risk factors contributing to DN in Mexican patients through the comparison of T2D patients with and without DN. Materials and methods: This cross-sectional study consisted of 509 subjects from Mexico who were classified as with DN and without DN. DN was assessed according to Douleur Neuropathique 4 questionnaire. Logistic regression analysis was performed to analyze risk factors contributing to DN. Results: The prevalence of DN in the studied population was 28.3%. The risk factors associated with DN were T2D duration (odds ratio [OR]: 2.51; 95% confidence interval [CI] 1.36-4.65), glycemic exposure index (OR: 1.82; 95% CI 1.01-3.64), lowand high-density lipoprotein levels (OR: 1.53; 95% CI 1.02-2.31), metformin treatment (OR: 2.08; 95% CI 1.11-3.91), diabetic retinopathy (OR: 1.65; 95% CI 1.07-2.54), and smoking (OR: 1.51; 95% CI 1.00-2.26). Conclusions: Therefore, the early identification of risk factors for DN development in Mexican population would allow implementing personalized strategies to improve the overall T2D patients’ quality of life and reduce healthcare costs in our country.

Keywords